000			02091 a2200589 4500
005			20250517065543.0
264		0	_c20160331
008			201603s 0 0 eng d
022			_a1791-7530
040			_aNLM _beng _cNLM
100	1		_aManso, Luís
245	0	0	_aFactors Associated with the Selection of First-line Bevacizumab plus Chemotherapy and Clinical Response in HER2-negative Metastatic Breast Cancer: ONCOSUR AVALOX Study. _h[electronic resource]
260			_bAnticancer research _cDec 2015
300			_a6941-50 p. _bdigital
500			_aPublication Type: Journal Article; Multicenter Study; Observational Study; Research Support, Non-U.S. Gov't
650	0	4	_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use
650	0	4	_aBevacizumab _xadministration & dosage
650	0	4	_aBreast Neoplasms _xdrug therapy
650	0	4	_aCross-Sectional Studies
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aNeoplasm Metastasis
650	0	4	_aPaclitaxel _xadministration & dosage
650	0	4	_aQuality of Life
650	0	4	_aReceptor, ErbB-2 _xmetabolism
650	0	4	_aTriple Negative Breast Neoplasms _xdrug therapy
700	1		_aPalomo, Andrés García
700	1		_aPérez Carrión, Ramón
700	1		_aCassinello, Javier
700	1		_aGallegos Sancho, Isabel
700	1		_aChacón López-Muñiz, Ignacio
700	1		_aOlier, Clara
700	1		_aFernández-Aramburo, Antonio
700	1		_aLlorca, Cristina
700	1		_aGonzález, Xavier
700	1		_aLlorente, Rosa
700	1		_aTorregrosa, Dolores
700	1		_aÁlvarez, Iñaki
700	1		_aGálve, Elena
700	1		_aBueno, Coralia
700	1		_aGarau, Isabel
700	1		_aGarcía, María José
700	1		_aGonzález-Santiago, Santiago
700	1		_aBallesteros, Ana Isabel
700	1		_aBlanco, Esperanza
700	1		_aGalán, Antonio
700	1		_aGonzález, Sonia
700	1		_aPerelló, Antonia
700	1		_aCortés-Funes, Hernán
700	1		_aGrávalos, Cristina
773	0		_tAnticancer research _gvol. 35 _gno. 12 _gp. 6941-50
999			_c25515145 _d25515145